Results 211 to 220 of about 132,338 (329)

Human ACE2 ELISA v1

The COVID-19pandemic has led to a significant number of individuals experiencing persistentpost-acute sequelae, commonly referred to as long COVID, following SARS-CoV-2infection. Similar symptoms, though less frequent, have also been observedafter COVID-19 vaccination.
openaire   +1 more source

A Cross‐Sectional Study Shows Emergence of the Delta, 19B, 20A, 20B, 19A, and Omicron Variants of SARS‐CoV‐2 in Burkina Faso: A Conundrum Within a Conundrum

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Context and Objective SARS‐CoV‐2 is an RNA virus that emerged in Wuhan, China. Adaptive mutations in its genome can influence the virus's pathogenicity, enhance its ability to evade the host immune system, and complicate vaccine development. This study aimed to identify the circulating SARS‐CoV‐2 variants in Burkina Faso and trace their origin.
Tatiana Doriane Lallogo, Lassina Traore, Ezeckiel B. TIBIRI, P. Abel Sorgho, Prosper Bado, T. Edwige Yelemkoure, Pakyendou E. Name, Valérie J. T. E. Bazie, Fidèle Tiendrebeogo, H. Karim Sombie, Abdoul Karim Ouattara, Serge Théophile Soubeiga, Abdou Azaque Zoure, Albert Théophane Yonli, Brice Bicaba, Rakissida Alfred Ouedraogo, Théodora Mahoukèdè Zohoncon, Florencia Wendkuuni Djigma, Assita LAMIEN/SANOU, Olga M. Lompo, Jacques Simpore   +20 more
wiley   +1 more source

Variants in ACE2; potential influences on virus infection and COVID-19 severity

, 2021
Behnaz Bakhshandeh, Shokufeh Ghasemian Sorboni, Amir‐Reza Javanmard, Seyed Saeed Mottaghi, Mohammad‐Reza Mehrabi, Farzaneh Sorouri, Ardeshir Abbasi, Zohreh Jahanafrooz   +7 more
openalex   +2 more sources

ACE2 wt Allele [PDF]

, 2020
openaire   +1 more source

COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride

Immunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.
ABSTRACT Introduction Despite extensive efforts to identify effective treatments for COVID‐19, preventive strategies remain essential. Bromhexine hydrochloride (BRH), an over‐the‐counter mucolytic with potential TMPRSS2 inhibition, may reduce viral entry and thus serve as a prophylactic agent.
Vanyo Mitev, Tsanko Mondeshki, Ani Miteva, Konstantin Tachkov, Violeta Dimitrova   +4 more
wiley   +1 more source

Functionalized Quantum Dot‐Based Portable Sensor for Dual Detection of Stress Biomarkers in Blood Serum and Saliva

Journal of Biophotonics, Volume 19, Issue 4, April 2026.
The graphical abstract illustrates the principle of fluorescence masking: increasing concentrations of stress biomarkers lead to progressive masking of quantum dots' fluorescence, enabling their quantitative detection on a biochip with a benchtop imager. ABSTRACT This work reports on the simultaneous detection of cellular stress biomarkers in blood and
Anusha Kishore, Arun Mathew Varughese, Bernhard Roth, Carsten Zeilinger   +3 more
wiley   +1 more source

Association of angiotensin converting enzyme type 2 serum level and gene polymorphisms with multiple sclerosis. [PDF]

Sci Rep
Al-Keilani MS, Abdelrazeq HM, Hendi NN, Jaradat SA.   +3 more
europepmc   +1 more source

Sex differences in structural cell‐mediated immune regulation: Implications for precision respiratory medicine

Clinical and Translational Discovery, Volume 6, Issue 2, April 2026.
Quocdai Vu, Wei Gao, Wujian Xu, Ximing Liao, Qiang Li   +4 more
wiley   +1 more source

The Open Reading Frame 7b of the SARS‐CoV‐2 Disperse Trans‐Golgi and Activate the NLRP3 Inflammasome

Journal of Medical Virology, Volume 98, Issue 4, April 2026.
ABSTRACT Inflammasomes orchestrate the inflammatory response against bacterial and viral infections, thereby initiating the synthesis of pro‐inflammatory cytokines, mainly IL‐1β and IL‐18. SARS‐CoV‐2 infection induces an inflammatory response mediated by the activation of NLRP1 and NLRP3 inflammasomes.
Julio García‐Villalba, Laura Hurtado‐Navarro, Diego Angosto‐Bazarra, Alberto Baroja‐Mazo, Pablo Pelegrin   +4 more
wiley   +1 more source

Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach. [PDF]

Gut
Prasad R, Adu-Rutledge Y, Ziani B, Floyd JL, Ready EL, Paul S, Sheini F, Sharma R, Rosencrans RF, Li Calzi S, Sielski MS, Medawar NG, Dutta R, Johnson EB, Qi X, Bansal M, Lamendella R, Wright JR, Verma SK, Boulton ME, Stevens BR, Vander Kooi CW, Sun RC, Oudit GY, Li Q, Grant MB.   +25 more
europepmc   +1 more source